The Transition From Phase II To Phase III Studies

被引:7
作者
Berthold, Dominik R. [1 ,2 ,3 ]
Gulamhusein, Aliya [1 ,2 ,4 ]
Jackson, John I. [1 ,2 ]
Tannock, Ian F. [1 ,2 ]
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Oncol Inst So Switzerland, Bellinzona, Switzerland
[4] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada
关键词
D O I
10.1200/JCO.2008.21.1938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1150 / 1151
页数:3
相关论文
共 4 条
[1]   THE FATE OF ABSTRACTS SUBMITTED TO A CANCER MEETING - FACTORS WHICH INFLUENCE PRESENTATION AND SUBSEQUENT PUBLICATION [J].
DEBELLEFEUILLE, C ;
MORRISON, CA ;
TANNOCK, IF .
ANNALS OF ONCOLOGY, 1992, 3 (03) :187-191
[2]   Economics of new oncology drug development [J].
DiMasi, Joseph A. ;
Grabowski, Henry G. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) :209-216
[3]   The costs of conducting clinical research [J].
Emanuel, EJ ;
Schnipper, LE ;
Kamin, DY ;
Levinson, J ;
Lichter, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4145-4150
[4]   Trends in clinical trials reports in common cancers between 1989 and 2000 [J].
Hillner, BE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1850-1858